Actually, it's difficult to be sure about anything involving erhc business operations since management no longer follows SEC disclosure regulations. The void of information regarding items listed below is why erhe is not allowed to be purchased at most U.S. brokerages, why it carries a skull and crossbones rating from OTC Markets, and why it trades on the expert market:
Who is Chairman of the Board? Who are the directors? How much are they paid?
How did erhc pay for huge litigation costs? Cash? Equity? Options? Percentage of block(s)?
Is the 400 page document still in effect?
And on and on.